Invention Grant
US08007792B2 Antibodies directed against hepatitis C virus E1E2 complex, compositions of HCV particles, and pharmaceutical compositions
有权
针对丙型肝炎病毒E1E2复合物的抗体，HCV颗粒的组合物和药物组合物
- Patent Title: Antibodies directed against hepatitis C virus E1E2 complex, compositions of HCV particles, and pharmaceutical compositions
- Patent Title (中): 针对丙型肝炎病毒E1E2复合物的抗体，HCV颗粒的组合物和药物组合物
-
Application No.: US12408080Application Date: 2009-03-20
-
Publication No.: US08007792B2Publication Date: 2011-08-30
- Inventor: Marie-Anne Petit , Colette Jolivet-Reynaud , Christian Trepo
- Applicant: Marie-Anne Petit , Colette Jolivet-Reynaud , Christian Trepo
- Applicant Address: FR Paris FR Marcy-l'Etoile
- Assignee: INSERM,Biomerieux SA
- Current Assignee: INSERM,Biomerieux SA
- Current Assignee Address: FR Paris FR Marcy-l'Etoile
- Agency: Young & Thompson
- Priority: EP03290822 20030401
- Main IPC: A61K39/395
- IPC: A61K39/395
Abstract:
New conformational antibodies are directed against HCV and more particularly to monoclonal antibodies. Described compositions of particles are liable to be recognized by the antibodies, as are pharmaceutical compositions containing them. Also described are HCV enveloped subviral particles or purified HCV enveloped complete viral particles, and the processes for preparing them.
Public/Granted literature
Information query
